News
BNGO
0.7611
-4.19%
-0.0333
Bionano Announces Publication Showing OGM's High Resolution Structural Variation Detection In Cancer Validated By Cas9-Directed Nanopore Sequencing
Bionano Genomics announces results of study comparing optical genome mapping to traditional cytogenetic methods. Optical genome mapping (OGM) can detect structural variants missed by other methods. OGM has the potential to provide a more comprehensive understanding of leukemia subtypes. The study was conducted by researchers at University Medical Center Groningen.
Benzinga · 10h ago
Weekly Report: what happened at BNGO last week (0415-0419)?
Weekly Report · 2d ago
BIONANO GENOMICS INC - DIAGENS RECEIVED CLASS I REGISTRATION AND APPROVAL FOR CO'S OGM REAGENTS FROM CHINA'S NATIONAL MEDICAL PRODUCTS ADMINISTRATION
Reuters · 04/17 12:01
Weekly Report: what happened at BNGO last week (0408-0412)?
Weekly Report · 04/15 10:45
Bionano Announces Publication Showing That OGM Detects Over 1250 Structural Variants, Including 56 Gene Fusions, In Pediatric Leukemia That Were Missed By Whole Genome Sequencing
Study used optical genome mapping to search for genomic variations in pediatric B-cell acute lymphoblastic leukemia. OGM and whole genome sequencing can potentially identify new therapeutic targets and improve personalized medicine in pediatric leukemia and other cancers. Of the 3,075 SVs detected, 1,255 were uniquely detected by OGM.
Benzinga · 04/11 12:16
Weekly Report: what happened at BNGO last week (0401-0405)?
Weekly Report · 04/08 10:50
BioNano Genomics Launches Offering to Bolster Finances
BioNano Genomics Inc has initiated a registered direct offering of over 6.5 million shares and warrants. The company could raise $10 million in gross proceeds. The funds are earmarked for general corporate needs. The offering is set to close in 2024. BNGO stock is down 2.7% today.
TipRanks · 04/05 13:42
Bionano Genomics Expects $10M in Proceeds from Direct Offering
Bionano Genomics agreed to the purchase and sale of its common stock. The San Diego genome analysis solutions provider will purchase and sell about 8.7 million shares. The offering is expected to close on or about April 8. The gross proceeds to the company are expected to be about $10 million.
Dow Jones · 04/04 18:00
Bionano announces $10M registered direct offering
Healthcare Bionano announces $10M registered direct offering of 8.7M shares of its common stock and warrants. The gross proceeds to the company from the offering are expected to be approximately $10 million. Bionanano Genomics, Inc. (BNGO) StockITP.
Seeking Alpha · 04/04 17:49
BIONANO ANNOUNCES $10 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES
Reuters · 04/04 17:44
Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics
Study compared optical genome mapping to classical cytogenetic techniques for analysis of solid tumor cancer samples. Optical genome mapping was shown to exclusively detect alterations in known oncogenes and tumor suppressor genes. OGM demonstrated high levels of concordance with FISH and KT.
Barchart · 04/03 07:00
BIONANO ANNOUNCES 9 POSTER PRESENTATIONS AND INTRODUCES NEW HIGH THROUGHPUT STRATYS™ SYSTEM AT THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING
Reuters · 04/02 12:00
Weekly Report: what happened at BNGO last week (0325-0329)?
Weekly Report · 04/01 10:47
Weekly Report: what happened at BNGO last week (0318-0322)?
Weekly Report · 03/25 10:50
Bionano Announces Publication Of A Breast Cancer Study Showing That The Number Of SVs Detected With OGM May Be Related To Prognosis, Tumor Progression And Chemotherapy Resistance
Study of optical genome mapping (OGM) in hereditary breast and ovarian cancer (HBOC) syndrome. Researchers found tumors with higher numbers of structural variations (SVs) tended to have more mutated genes and altered signaling pathways. OGM was able to detect novel gene fusions in cancer with high accuracy.
Benzinga · 03/19 12:15
Weekly Report: what happened at BNGO last week (0311-0315)?
Weekly Report · 03/18 10:48
Weekly Report: what happened at BNGO last week (0304-0308)?
Weekly Report · 03/11 10:46
BioNano Genomics (BNGO) Gets a Hold from Maxim Group
TipRanks · 03/09 16:15
More
Webull provides a variety of real-time BNGO stock news. You can receive the latest news about Bionano Genomics Inc through multiple platforms. This information may help you make smarter investment decisions.
About BNGO
Bionano Genomics, Inc. is a genomics company. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. Through Lineagen, Inc., the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).